These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9264479

  • 1. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
    Fisch A, Tobusch K, Veit K, Meyer J, Darius H.
    Circulation; 1997 Aug 05; 96(3):756-60. PubMed ID: 9264479
    [Abstract] [Full Text] [Related]

  • 2. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H, Binz C, Veit K, Fisch A, Meyer J.
    J Am Coll Cardiol; 1995 Sep 05; 26(3):800-6. PubMed ID: 7543911
    [Abstract] [Full Text] [Related]

  • 3. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul 05; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 4. Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets.
    Darius H, Veit K, Binz C, Fisch A, Meyer J.
    Agents Actions Suppl; 1995 Jul 05; 45():77-83. PubMed ID: 7536385
    [Abstract] [Full Text] [Related]

  • 5. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 05; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 6. Internalization and down-regulation of the prostacyclin receptor in human platelets.
    Giovanazzi S, Accomazzo MR, Letari O, Oliva D, Nicosia S.
    Biochem J; 1997 Jul 01; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
    [Abstract] [Full Text] [Related]

  • 7. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM, Strange PG.
    Biosci Rep; 1984 Nov 01; 4(11):941-8. PubMed ID: 6084527
    [Abstract] [Full Text] [Related]

  • 8. Iloprost antagonizes the increase in internal calcium concentration induced by alpha-thrombin in human platelets: a study of desensitization.
    Cecchi E, Capone L, Ruocco C, Fazzini A, Mugelli A, Giotti A, Failli P.
    Cardiovasc Drugs Ther; 1995 Dec 01; 9(6):773-7. PubMed ID: 8850381
    [Abstract] [Full Text] [Related]

  • 9. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA.
    Prostaglandins; 1997 Jan 01; 53(1):21-35. PubMed ID: 9068064
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Jan 01; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 11. Activation of the cloned platelet thrombin receptor decreases the pertussis-toxin-dependent ADP-ribosylation of the membrane and soluble inhibitory guanine-nucleotide-binding-alpha proteins. Inhibition by the prostacyclin analog, iloprost.
    Wilhelm B, Siess W.
    Eur J Biochem; 1993 Aug 15; 216(1):81-8. PubMed ID: 7689967
    [Abstract] [Full Text] [Related]

  • 12. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
    Hiroi T, Maruyama K, Hattori K, Ohnuki T, Nagatomo T, Watanabe K, Yamamoto T, Hara Y.
    Jpn J Pharmacol; 1997 May 15; 74(1):37-43. PubMed ID: 9195295
    [Abstract] [Full Text] [Related]

  • 13. Prostacyclin receptor expression on platelets of humans with type 2 diabetes is inversely correlated with hemoglobin A1c levels.
    Knebel SM, Sprague RS, Stephenson AH.
    Prostaglandins Other Lipid Mediat; 2015 May 15; 116-117():131-5. PubMed ID: 25617843
    [Abstract] [Full Text] [Related]

  • 14. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE, Brown AM, Bund S, Cooper DG, Egan JW, Hallam TJ, Heagerty AM, Hickey DM, Kaumann AJ, Keen M.
    Br J Pharmacol; 1991 Jan 15; 102(1):260-6. PubMed ID: 2043927
    [Abstract] [Full Text] [Related]

  • 15. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
    Seiler SM, Brassard CL, Federici ME, Buchanan JO, Zavoico GB, Fleming JS, Meanwell NA.
    Thromb Res; 1994 Apr 15; 74(2):115-23. PubMed ID: 8029812
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA, Jones RL, MacDermot J, Wilson NH.
    Br J Pharmacol; 1986 Mar 15; 87(3):543-51. PubMed ID: 3026540
    [Abstract] [Full Text] [Related]

  • 17. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK, Ullian ME, Halushka PV.
    J Pharmacol Exp Ther; 1992 Jul 15; 262(1):238-45. PubMed ID: 1378092
    [Abstract] [Full Text] [Related]

  • 18. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man.
    Modesti PA, Fortini A, Poggesi L, Boddi M, Abbate R, Gensini GF.
    Thromb Res; 1987 Dec 15; 48(6):663-9. PubMed ID: 2448896
    [Abstract] [Full Text] [Related]

  • 19. Guanine nucleotide sensitivity of [3H]iloprost binding to prostacyclin receptors.
    Keen M, Kelly E, MacDermot J.
    Eur J Pharmacol; 1991 Jun 19; 207(2):111-7. PubMed ID: 1715275
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H, Michael-Hepp J, Thierauch KH, Fisch A.
    Eur J Pharmacol; 1994 Jun 13; 258(3):207-13. PubMed ID: 7522176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.